NCT03674411 2026-01-06Trial Evaluating MGTA-456 in Patients With High-Risk MalignancyMasonic Cancer Center, University of MinnesotaPhase 2 Active not recruiting22 enrolled 19 charts
NCT03113500 2025-11-14Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell LymphomaCity of Hope Medical CenterPhase 2 Active not recruiting48 enrolled 8 charts